China Resources Shuanghe (600062. SH) subsidiary obtaining CEP certificate for sodium valproate active pharmaceutical ingredient

Intelligence financial APP news, China Resources Shuanghe (600062.SH) issued an announcement recently. The company's controlling subsidiary, China Resources Shuanghe Xiang Chinese Medicine (Hunan) Co., Ltd., has received the Certificate of Suitability of European Pharmacopoeia (CEP certificate) issued by the European Directorate for the Quality of Medicines (EDQM) for the raw material of sodium valproate. Sodium valproate is a drug used to treat mental disorders, mainly for epilepsy and mania.